
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The companys best-in-class product offerings include Arteriocytes market-leading Magellan Autologous Platelet Separator and Istos bone-growth and cell-therapy products including InQu Bone Graft Extender & Substitute; and InfluxTM, a natural bone-graft material
Orthobiologics,medical device,products for spine and orthopedics,bone grafts,cell-therapy,regenerative medicine,minimally invasive spine and orthopedic solutions,spinal disc regeneration,and platelet rich plasma
Isto biologics operates in the Medical equipment manufacturing industry.
Isto biologics's revenue is 11m - 100m
Isto biologics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.